McKesson Corporation vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? McKesson Corporation trades at $898 (market cap $105.14B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.21. The key difference: McKesson Corporation pays a 0.42% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and McKesson Corporation is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| MCK | USIG | |
|---|---|---|
Market Cap | $105.14B | — |
Sector | Health | Fixed Income |
52-Week High | $995.69 | $52.69 |
52-Week Low | $659.01 | $50.18 |
Enterprise Value | $111.67B | — |
Dividend Yield | 0.42% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
USIG trades at $50.40 with minimal daily movement (+0.16%). Technical indicators show a bearish bias with moving averages signaling caution, though oscillators remain neutral. The company maintains consistent dividend distributions, with recent payouts of $0.20-$0.21 per share. Recent news includes AM Best affirming credit ratings for subsidiaries following a transaction with Tiptree Inc.
Investment outlook remains cautious given bearish technical signals and limited fundamental data availability. The steady dividend history provides income appeal, but investors face uncertainty from incomplete financial metrics. Key risks include potential volatility from institutional positioning changes and transaction integration challenges with Tiptree.
Trailing returns across standard periods
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →